Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Vannucchi and Danilo Malandrino.
Connection Strength
0.449
-
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
Score: 0.225
-
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. Int J Lab Hematol. 2020 12; 42(6):e270-e273.
Score: 0.224